173 related articles for article (PubMed ID: 36835316)
41. [Extracorporeal shock wave therapy for chronic prostatitis / chronic pelvic pain syndrome: A meta-analysis].
Liao B; Mou XX; Liu JB; Wu T; Cui S
Zhonghua Nan Ke Xue; 2019 Oct; 25(10):914-922. PubMed ID: 32233224
[TBL] [Abstract][Full Text] [Related]
42. Hwanglyunhaedok Pharmacopuncture versus Saline Pharmacopuncture on Chronic Nonbacterial Prostatitis/Chronic Pelvic Pain Syndrome.
Seong KM; Jang G; Kim DW; Kim S; Song BK
J Acupunct Meridian Stud; 2017 Aug; 10(4):245-251. PubMed ID: 28889841
[TBL] [Abstract][Full Text] [Related]
43. Prostate-to-bladder cross-sensitization in a model of zymosan-induced chronic pelvic pain syndrome in rats.
Aydogdu O; Gocun PU; Aronsson P; Carlsson T; Winder M
Prostate; 2021 Mar; 81(4):252-260. PubMed ID: 33465254
[TBL] [Abstract][Full Text] [Related]
44. Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.
Franco JV; Turk T; Jung JH; Xiao YT; Iakhno S; Garrote V; Vietto V
Cochrane Database Syst Rev; 2018 May; 5(5):CD012551. PubMed ID: 29757454
[TBL] [Abstract][Full Text] [Related]
45. Morphological reseach on expression of inflammatory mediators in murine models of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) induced by T2 antigen.
Wang W; Naveed M; Majeed F; Cui X; Ihsan AU; Liu Z; Zubair HM; Tang M; Sohail M; Xiaohui Z
Andrologia; 2019 Dec; 51(11):e13435. PubMed ID: 31613015
[TBL] [Abstract][Full Text] [Related]
46. A prospective study on association of prostatic calcifications with sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
Zhao Z; Xuan X; Zhang J; He J; Zeng G
J Sex Med; 2014 Oct; 11(10):2528-36. PubMed ID: 24735240
[TBL] [Abstract][Full Text] [Related]
47. A nanoparticle-coupled T2 peptide induces immune tolerance and ameliorates chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in mice model.
Cao Y; Cheng Y; Ihsan AU; Khan FU; Xie D; Cui X; Wang W; Zhou X
Fundam Clin Pharmacol; 2019 Jun; 33(3):267-276. PubMed ID: 30471234
[TBL] [Abstract][Full Text] [Related]
48. Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function through increased endothelial dysfunction, oxidative stress, apoptosis, and corporal fibrosis in a rat model.
Hu Y; Niu X; Wang G; Huang J; Liu M; Peng B
Andrology; 2016 Nov; 4(6):1209-1216. PubMed ID: 27565759
[TBL] [Abstract][Full Text] [Related]
49. Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.
Franco JV; Turk T; Jung JH; Xiao YT; Iakhno S; Garrote V; Vietto V
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012551. PubMed ID: 29372565
[TBL] [Abstract][Full Text] [Related]
50. Effects of dutasteride in a rat model of chemically induced prostatic inflammation-Potential role of estrogen receptor β.
Mizoguchi S; Mori K; Shin T; Wang Z; DeFranco DB; Yoshimura N; Mimata H
Prostate; 2020 Dec; 80(16):1413-1420. PubMed ID: 32941694
[TBL] [Abstract][Full Text] [Related]
51. Melatonin attenuates prostatic inflammation and pelvic pain via Sirt1-dependent inhibition of the NLRP3 inflammasome in an EAP mouse model.
Chen J; Zhang LG; Du HX; Zhan CS; Liu Y; Zhang M; Chen XG; Wen LP; Zhang L; Liang CZ
Prostate; 2021 Nov; 81(15):1179-1190. PubMed ID: 34418127
[TBL] [Abstract][Full Text] [Related]
52. Establishment of a rat model of chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) induced by immunization with a novel peptide T2.
Ihsan AU; Khan FU; Nawaz W; Khan MZ; Yang M; Zhou X
Biomed Pharmacother; 2017 Jul; 91():687-692. PubMed ID: 28499240
[TBL] [Abstract][Full Text] [Related]
53. Effect of tadalafil on chronic pelvic pain and prostatic inflammation in a rat model of experimental autoimmune prostatitis.
Okamoto K; Kurita M; Yamaguchi H; Numakura Y; Oka M
Prostate; 2018 Jul; 78(10):707-713. PubMed ID: 29577372
[TBL] [Abstract][Full Text] [Related]
54. Dietary habits and lifestyle related to the effectiveness of low-intensity extracorporeal shock wave therapy for chronic prostatitis/chronic pelvic pain syndrome-like symptoms: Initial results.
Bian Z; Jin C; Mo F; Zhang S; Meng J; Zhang M; Zhang L; Chen X; Hao Z; Song Z; Liang C
Andrologia; 2022 Oct; 54(9):e14490. PubMed ID: 35671994
[TBL] [Abstract][Full Text] [Related]
55. [Intraprostatic urinary reflux associated prostatitis caused by partial urethral obstruction in the rat model].
Liu W; Li SW; Zheng XM; Hu LQ; Luo Y
Zhonghua Nan Ke Xue; 2008 Jan; 14(1):11-4. PubMed ID: 18297803
[TBL] [Abstract][Full Text] [Related]
56. Treatment with low-energy shock wave alleviates pain in an animal model of uroplakin 3A-induced autoimmune interstitial cystitis/painful bladder syndrome.
Li H; Zhang Z; Peng J; Xin Z; Li M; Yang B; Fang D; Tang Y; Guo Y
Investig Clin Urol; 2019 Sep; 60(5):359-366. PubMed ID: 31501798
[TBL] [Abstract][Full Text] [Related]
57. Post-prostatic-massage urine exosomes of men with chronic prostatitis/chronic pelvic pain syndrome carry prostate-cancer-typical microRNAs and activate proto-oncogenes.
Schneider L; Dansranjav T; Neumann E; Yan H; Pilatz A; Schuppe HC; Wagenlehner F; Schagdarsurengin U
Mol Oncol; 2023 Mar; 17(3):445-468. PubMed ID: 36321189
[TBL] [Abstract][Full Text] [Related]
58. IL-17 is not essential for inflammation and chronic pelvic pain development in an experimental model of chronic prostatitis/chronic pelvic pain syndrome.
Motrich RD; Breser ML; Sánchez LR; Godoy GJ; Prinz I; Rivero VE
Pain; 2016 Mar; 157(3):585-597. PubMed ID: 26882345
[TBL] [Abstract][Full Text] [Related]
59. Quercetin protects against chronic prostatitis in rat model through NF-κB and MAPK signaling pathways.
Meng LQ; Yang FY; Wang MS; Shi BK; Chen DX; Chen D; Zhou Q; He QB; Ma LX; Cheng WL; Xing NZ
Prostate; 2018 Aug; 78(11):790-800. PubMed ID: 29654614
[TBL] [Abstract][Full Text] [Related]
60. Chronic Prostatitis and/or Chronic Pelvic Pain as a Psychoneuromuscular Disorder-A Meta-analysis.
Anderson RU; Wise D; Nathanson BH
Urology; 2018 Oct; 120():23-29. PubMed ID: 30056195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
